search
Back to results

Patient Guided Psychiatric Admissions

Primary Purpose

Schizophrenia, Bipolar Disorder

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
wait list control
admissions contract
Sponsored by
St. Olavs Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Schizophrenia focused on measuring Schizophrenia, bipolar disorder, Long term care, patient admission

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • schizophrenia or bipolar disorder
  • long term care
  • established relationship with the ward

Exclusion Criteria:

  • extensive substance use problems
  • self-destructive behavior
  • not able to consent

Sites / Locations

  • St.Olavs hospital, Psykisk helsevern, Nidaros DPS

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

admissions contract

wait list control

Arm Description

contract regarding "patient-guided admissions"

1 year on waiting list

Outcomes

Primary Outcome Measures

Patient activation/coping
Patient Activation Measure (PAM 13)
Patient activation/coping
Patient Activation Measure (PAM 13)

Secondary Outcome Measures

Number of admissions
Number of admissions in CMHC, psychiatric hospital of community rehabilitation centre
Total number of inpatient days
Total number of inpatient days in CMHC, psychiatric hospital or community rehabilitation centre
Number of outpatient consultations
Number of outpatient consultations in primary care, in CMHC and psychiatric hospital
Number of involuntary admissions
Number of involuntary admissions either as inpatient or outpatient
Symptoms/functioning and recovery
Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)
Symptoms/functioning and recovery
Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)

Full Information

First Posted
May 19, 2010
Last Updated
March 31, 2017
Sponsor
St. Olavs Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01133587
Brief Title
Patient Guided Psychiatric Admissions
Official Title
Patient Guided Psychiatric Admissions (Self-referral to Inpatient Beds)
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
May 2010 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
St. Olavs Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To meet the requirement for increased patient involvement, several Community Mental Health Centres (CMHC) have initiated a service called "patient-guided admissions". The investigators will compare a group with "patient guided admission/self-referral to inpatient beds" with a group having treatment as usual. It is expected that patients in the intervention group will experience more increased feeling of coping (patient activation) after 4 months and 12 months as a result of participating in "patient-guided admissions" than patients getting treatment as usual. In addition the total number of inpatient days either in the CMHC, psychiatric hospital or community rehabilitation centre is expected to be clearly lower in the intervention group than in the 'treatment-as-usual' group during one year after intake. Also the number of involuntary admissions either as inpatient or outpatient will be significant lower in the intervention group than the 'treatment-as-usual' group.The number of admissions in CMHC and psychiatric hospital, as well as the number of outpatient consultations in primary care, CMHC and psychiatric hospitals, will be lower in the intervention group than in the 'treatment-as-usual' group. Patients in the intervention group will experience improved mental health, increased feeling of coping (patient activation) and increased experience of recovery after 4 months and 12 months as a result of participating in "patient-guided admissions".
Detailed Description
Participants will be patients with psychosis or bipolar disorders. Patients in the intervention group will have a contract on "self-referral to inpatient beds" for one year. They can call the CMHC directly and ask for a bed for until 5 nights. The patients in the 'treatment-as-usual' group will follow common procedures by either contacting their general practitioner, emergency department or duty doctor, and they will be offered a "self-referral to inpatient bed" contract after a year if they satisfy the inclusion criteria. Regardless of the participation in the intervention group, the patients can also be ordinary admitted during the project period by a doctor via regular procedures in both hospital and CMHC if there is a need for this. All admissions will appear in the register data.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia, Bipolar Disorder
Keywords
Schizophrenia, bipolar disorder, Long term care, patient admission

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
53 (Actual)

8. Arms, Groups, and Interventions

Arm Title
admissions contract
Arm Type
Experimental
Arm Description
contract regarding "patient-guided admissions"
Arm Title
wait list control
Arm Type
Active Comparator
Arm Description
1 year on waiting list
Intervention Type
Other
Intervention Name(s)
wait list control
Intervention Description
Patient-guided admissions contract regarding "patient-guided admissions" starting a year after.
Intervention Type
Behavioral
Intervention Name(s)
admissions contract
Intervention Description
contract regarding "patient-guided admissions" starting immediately
Primary Outcome Measure Information:
Title
Patient activation/coping
Description
Patient Activation Measure (PAM 13)
Time Frame
4 months
Title
Patient activation/coping
Description
Patient Activation Measure (PAM 13)
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Number of admissions
Description
Number of admissions in CMHC, psychiatric hospital of community rehabilitation centre
Time Frame
12 months
Title
Total number of inpatient days
Description
Total number of inpatient days in CMHC, psychiatric hospital or community rehabilitation centre
Time Frame
12 months
Title
Number of outpatient consultations
Description
Number of outpatient consultations in primary care, in CMHC and psychiatric hospital
Time Frame
12 months
Title
Number of involuntary admissions
Description
Number of involuntary admissions either as inpatient or outpatient
Time Frame
12 months
Title
Symptoms/functioning and recovery
Description
Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)
Time Frame
4 months
Title
Symptoms/functioning and recovery
Description
Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: schizophrenia or bipolar disorder long term care established relationship with the ward Exclusion Criteria: extensive substance use problems self-destructive behavior not able to consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lasse Eriksen, PhD
Organizational Affiliation
St. Olavs Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
St.Olavs hospital, Psykisk helsevern, Nidaros DPS
City
Trondheim
ZIP/Postal Code
7440
Country
Norway

12. IPD Sharing Statement

Citations:
PubMed Identifier
27659102
Citation
Moljord IE, Helland-Hansen KA, Salvesen O, Olso TM, Gudde CB, Rise MB, Steinsbekk A, Eriksen L. Short time effect of a self-referral to inpatient treatment for patients with severe mental disorders: a randomized controlled trial. BMC Health Serv Res. 2016 Sep 22;16(1):513. doi: 10.1186/s12913-016-1712-z.
Results Reference
result
PubMed Identifier
28096034
Citation
Moljord IEO, Lara-Cabrera ML, Salvesen O, Rise MB, Bjorgen D, Antonsen DO, Olso TM, Evensen GH, Gudde CB, Linaker OM, Steinsbekk A, Eriksen L. Twelve months effect of self-referral to inpatient treatment on patient activation, recovery, symptoms and functioning: A randomized controlled study. Patient Educ Couns. 2017 Jun;100(6):1144-1152. doi: 10.1016/j.pec.2017.01.008. Epub 2017 Jan 11.
Results Reference
result
PubMed Identifier
27739334
Citation
Sigrunarson V, Moljord IE, Steinsbekk A, Eriksen L, Morken G. A randomized controlled trial comparing self-referral to inpatient treatment and treatment as usual in patients with severe mental disorders. Nord J Psychiatry. 2017 Feb;71(2):120-125. doi: 10.1080/08039488.2016.1240231. Epub 2016 Oct 14.
Results Reference
result

Learn more about this trial

Patient Guided Psychiatric Admissions

We'll reach out to this number within 24 hrs